Michigan Head-Pain and Neurological Institute

Ann Arbor, Michigan 48112

1 studies enrolling now · 37 studies all time

What they study most

Acute Migraine, Acute Migraine With or Without Aura, Acute Pain, Acute Treatment of Migraine, Back Muscle Spasm, Back Pain, Back Spasm Upper, Back Strain, Chronic Cluster Headache, Chronic Migraine, Chronic Migraine in Children, Diabetic Neuropathy, Painful

Studies at this site

• Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine — Recruiting now
• A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine — Recruiting now
• A Study of Eptinezumab in Pediatric Participants With Episodic Migraine — Recruiting now
• A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine — Recruiting now
• Efficacy and Safety of Erenumab in Pediatric Participants With Episodic Migraine — Running, not enrolling
• Erenumab - Comprehensive Assessment of Efficacy in (High-Frequency) Episodic Migraine — Completed
• Efficacy and Safety Trial of BHV-2100 for the Acute Treatment of Migraine — Completed
• Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine — Completed
• A Study to Evaluate the Efficacy and Safety of Erenumab in Adults With Medication Overuse Headache — Completed
• A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Elismetrep (K-304) in the Treatment of Migraine — Completed
• A Study in Children and Young People With Migraine to Learn What the Body Does to Eptinezumab — Completed
• Study to Assess the Safety and Efficacy of ONZETRA® Xsail® for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents — Stopped early
• Dose Ranging Study of Rimegepant (BMS-927711) for the Acute Treatment of Migraine — Completed
• Open Label Safety Study in Acute Treatment of Migraine — Completed
• Evaluation of Galcanezumab in the Prevention of Chronic Migraine — Completed
• Efficacy and Safety of Tolperisone in Subjects With Pain Due to Acute Back Muscle Spasm — Completed
• A Study of LY2951742 (Galcanezumab) in Participants With Cluster Headache — Completed
• A Study to Evaluate the Efficacy and Safety of Eptinezumab Administered Intravenously in Participants Experiencing Acute Attack of Migraine — Completed
• RN624 For Pain Of Post-Herpetic Neuralgia — Completed
• A Study Of The Analgesic (Pain-Relief) Effects Of Tanezumab In Adult Patients With Diabetic Peripheral Neuropathy — Stopped early
• Placebo-controlled Safety and Efficacy Study of Pregabalin in Subjects With Post-traumatic Peripheral Neuropathic Pain — Completed
• A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression — Completed
• Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy — Completed
• A Study of Galcanezumab in Participants With Chronic Cluster Headache — Completed
• An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine — Completed
• A Study of Galcanezumab (LY2951742) in Adults With Treatment-Resistant Migraine — Completed
• Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study — Completed
• A Study Of Galcanezumab In Participants With Episodic Cluster Headache — Completed
• Efficacy, Safety, and Tolerability of Multiple Dosing Regimens of Oral Atogepant (AGN-241689) in Episodic Migraine Prevention — Completed
• A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache — Completed
• Study to Determine the Efficacy and Safety of ELS-M11 in Acute Migraine — Completed
• A Clinical Trial To Evaluate PF-05089771 On Its Own And As An Add-On Therapy To Pregabalin (Lyrica) For The Treatment Of Pain Due To Diabetic Peripheral Neuropathy (DPN) — Completed
• Civamide Nasal Solution for Postherpetic Neuralgia of the Trigeminal Nerve — Stopped early
• Evaluation of Civamide Patch in Treatment of Postherpetic Neuralgia and Post-Incisional Neuralgia — Completed
• Study of NXN 188 for the Treatment of Migraine With Aura — Completed
• Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia — Completed
• Study of Lornoxicam or Placebo for Acute Treatment of the Headache of Migraine. — Completed